Tabula Rasa HealthCare, Inc. (TRHC) is devoted to leveraging technology to improve healthcare. TRHC has assembled an experienced and accomplished leadership team, who, along with our board of directors, have developed a proprietary solution set of technology-enabled products and services for medication management and risk adjustment.
TRHC decreases medication-related risk, reduces adverse drug events, enhances compliance and quality of care, and improves medication outcomes. CEO Dr. Calvin Knowlton offers some TRHC background and insight in an interview after winning the Remington Honor Medal. In the clip below, Dr. Knowlton is introduced by American Pharmacists Association President Matt Osterhaus and interviewed by Mark L Walberg.
In the interview featured below, Dr. Knowlton discusses how TRHC leverages technology to improve healthcare. SmartCEO conducted this interview after CareKinesis won the Voltage Award for Technology Innovator.